HIV Clinical and Translational Research

Activities

The HIV Clinical and Translational Research (HIV-CTR) Group is interested in clinically oriented research in the field of resistance to antiviral therapy and transmission, as well as providing new translational knowledge on HIV cure and on HIV immunopathogenesis using humanized mouse models. The Group is a partner in several European HIV and HCV networks, collaborates with lifescience and biotech companies, and has built up a network in emerging countries (mainly in Africa) to support knowledge and technology transfer. The Group provides specialized technical support for the clinical follow-up of HIV and HCV-infected patients and is the first supplier of public health information for these infections in Luxembourg.

Collaborations:

• European Society for Translational Antiviral Research (ESAR) and the Hepvir working group for hepatitis B     and C
• EURESIST
• Breach HIV Cure consortium
• the Monod consortium for the clinical trial NCT01127204, evaluation of simplified antiretroviral treatment strategies in HIV infected children treated by antiretroviral before one year of age
• the COST action CM1407, NatChemdrugs

Research projects

• HIV Molecular Epidemiology in Europe, the SPREAD surveillance program
• Toxicomania, hepatitis C and substitution: epidemiological, behavioral and clinical study in Luxembourg
• Development of heteromultimeric multifunctional therapeutic molecules activating the complement action towards target cells
• Assessment of the sequential events driving immune activation in the gut during acute HIV infection by using an in vivo model of humanized mice
• Challenging organic syntheses inspired by nature - from natural products chemistry to drug discovery